摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-dibromo-6-isopropylaniline | 81090-45-1

中文名称
——
中文别名
——
英文名称
2,4-dibromo-6-isopropylaniline
英文别名
2,4-dibromo-6-propan-2-ylaniline
2,4-dibromo-6-isopropylaniline化学式
CAS
81090-45-1
化学式
C9H11Br2N
mdl
——
分子量
293.001
InChiKey
OKIHDLUSXGDARZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    304.6±37.0 °C(Predicted)
  • 密度:
    1.682±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    26
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2921420090
  • 危险性防范说明:
    P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
  • 危险性描述:
    H302,H312,H315,H319,H332,H335

反应信息

  • 作为反应物:
    描述:
    2,4-dibromo-6-isopropylaniline2-均三甲苯基-2,5,6,7-四氢吡咯并[2,1-C][1,2,4]三唑-4-鎓氯化物N,N-二异丙基乙胺硫脲 作用下, 以 甲苯 为溶剂, 反应 40.0h, 生成 1'-(2,4-dibromo-6-isopropylphenyl)spiro[indene-2,3'-pyrrolidine]-1,2',3,5'-tetraone
    参考文献:
    名称:
    NHC催化的N-芳基马来酰亚胺的不对称化导致N-芳基琥珀酰亚胺的对映选择性合成
    摘要:
    尽管导致手性C-C键的轴向合成导致联芳基和相关化合物的对映选择性合成是众所周知的,但带有轴向手性C-N键的化合物的相关合成却相对较少。本文描述的是通过N-芳基马来酰亚胺的去对称化作用,对具有轴向手性C-N键的N-芳基琥珀酰亚胺进行N-杂环卡宾催化的对位选择性合成。NHC涉及分子间的二醛与前手性N-芳基马来酰亚胺的分子间Stetter-aldol级联反应,然后氧化得到N-芳基琥珀酰亚胺,具有良好的收率和ee值。还提供了有关C–N键的旋转势垒,温度依赖性的初步研究,以及有关机理的详细DFT研究。
    DOI:
    10.1002/anie.202016938
点击查看最新优质反应信息

文献信息

  • [EN] BLUE LUMINESCENT COMPOUND AND DIASTEREOMERS THEREOF<br/>[FR] COMPOSÉ LUMINESCENT BLEU ET SES DIASTÉRÉOISOMÈRES
    申请人:DU PONT
    公开号:WO2015175130A1
    公开(公告)日:2015-11-19
    There is provided a composition which is capable of being separated into diastereomeric pairs of enantiomers. The compound has (Formula I) In Formula I: Ar' can be aryl or deuterated aryl; R1 can be H, D, alkyl, silyl, aryl, or a deuterated analog thereof; R2 is different from R1 and can be H, D, alkyl, silyl, aryl, or a deuterated analog thereof, with the proviso that only one of R1 and R2 is H or D; R3 is the same or different at each occurrence and can be D, alkyl, silyl, aryl, or a deuterated analog thereof; a is an integer from 0-3; and b is an integer from 0-4.
    提供了一种能够分离成对映异构体对的组合物。该化合物具有(化学式I)在化学式I中:Ar'可以是芳基或氘代芳基;R1可以是H、D、烷基、硅基、芳基或其氘代物;R2与R1不同,可以是H、D、烷基、硅基、芳基或其氘代物,但R1和R2中只有一个是H或D;R3在每次出现时可以相同也可以不同,可以是D、烷基、硅基、芳基或其氘代物;a是0-3之间的整数;b是0-4之间的整数。
  • Highly Quantum Efficient Phosphorescent Sky Blue Emitters Based on Diastereomeric Iridium(III) Complexes of Atropisomeric 5-Aryl-4<i>H</i>-1,2,4-triazole Ligands
    作者:Jerald Feldman、Giang D. Vo、Charles D. McLaren、Troy C. Gehret、Kyung-Ho Park、Jeffrey S. Meth、Will J. Marshall、Joseph Buriak、Lois M. Bryman、Kerwin D. Dobbs、Thomas H. Scholz、Steve G. Zane
    DOI:10.1021/acs.organomet.5b00198
    日期:2015.8.10
    Homoleptic fac-(IrL3)-L-III complexes of 5-ary1-4H-1,2,4-triazole ligands are sky blue emitters. When unsymmetrically substituted, the triazole ligands exhibit atropisomerism, and upon cyclometalation to Ir(III) a mixture of diastereomers Ph is formed. We have isolated and structurally characterized all four possible diastereomers of the fac-(IrL3)-L-III complex formed Ph upon cyclometalation of an atropisomeric 5-ary1-4H-1,2,4-triazole ligand onto The phosphorescent blue emitting materials reported herein are among the most efficient to date, with quantum efficiencies above 95%.
  • N-(2,4,7-trinitrofluorenylidene)anilines—new electron transport materials in positive charge electrophotography
    作者:Masaki Matsui、Katsuyoshi Shibata、Hiroshige Muramatsu、Hiroyuki Nakazumi
    DOI:10.1039/jm9960601113
    日期:——
    New electron transport materials, N-(2,4,7-trinitrofluorenylidene)-2,6-dialkyanilines, show excellent properties in positive charge electrophotography. Single-crystal X-ray diffraction analyses of two of these compounds are reported. The high solubility of N-(2,4,7-trinitrofluorenylidene)-2,6-diethylanilines could be mainly attributed to the loss of overlap between intermolecular fluorene rings due to the bulkiness of the ethyl groups.
  • Catalytic Atroposelective Synthesis of <i>N</i>-Aryl Quinoid Compounds
    作者:Sagar D. Vaidya、Sean T. Toenjes、Nobuyuki Yamamoto、Sean M. Maddox、Jeffrey L. Gustafson
    DOI:10.1021/jacs.9b12994
    日期:2020.2.5
    Diarylamines and related scaffolds are among the most common chemotypes in modern drug discovery. While they can potentially possess two chiral axes, there are no studies on their enantioselective synthesis, as these axes typically possess lower stereochemical stabilities. Herein, we report a chiral phosphoric acid catalyzed atroposelective electrophilic halogenation of N-aryl quinoids, a class of compounds that are analogous to diarylamines. This chemistry yields a large range of stereochemically stable N-aryl quinoids in excellent yields and atroposelectivity. This work represents the first example of the atroposelective synthesis of a diarylamine-like scaffold and will serve as a gateway to fundamental and applied studies on the scarcely studied chirality of these ubiquitous chiral scaffolds.
  • USE OF COMPOSITIONS MODULATING CHROMATIN STRUCTURE FOR GRAFT VERSUS HOST DISEASE (GVHD)
    申请人:Dana-Farber Cancer Institute, Inc.
    公开号:US20190000860A1
    公开(公告)日:2019-01-03
    In some aspects, the instant disclosure relates to methods of treating chronic graft versus host disease (cGVHD). In some embodiments, the method comprises administering to a subject in need thereof a EZH2 inhibitor, a Bcl6 inhibitor and/or BRD4 inhibitor. The present disclosure is based, at least in part, on the discovery that enhancer of zeste homolog 2 (EZH2) inhibitors, B-cell lymphoma 6 protein (Bcl6) inhibitors and/or bromodomain-containing protein 4 (BRD4) inhibitors can be used to treat chronic graft versus host disease (cGVHD).
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐